As of now, Guyana reports a pregnant women living with hiv antiretroviral therapy coverage for pmtct of 87%, signifying an increase of 17% (24.3%) from 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Guyana
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Guyana
PMTCT antiretroviral therapy coverage
More indicators for Guyana
Male unintentional poisoning
0.1
0.0
(2019)
Female wasting in children
5.6%
-0.6%
(2019)
Female prevalence of HIV
0.4%
+0.1%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar326
+intl dollar67
(2021)
Birth registration
98.1%
+9.4%
(2020)
Contraceptive modern method prevalence
28.6%
-4%
(2020)
Guyana PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 87% | +17% |
| 2021 | 70% | +20% |
| 2020 | 50% | -14% |
| 2019 | 64% | +7% |
| 2018 | 57% | +9% |
| 2017 | 48% | -11% |
| 2016 | 59% | -3% |
| 2015 | 62% | +5% |
| 2014 | 57% | -13% |
| 2013 | 70% | +16% |
| 2012 | 54% | +4% |
| 2011 | 50% | +11% |
| 2010 | 39% | -21% |
| 2009 | 60% | +9% |
| 2008 | 51% | +9% |
| 2007 | 42% | +11% |
| 2006 | 31% | -11% |
| 2005 | 42% | +13% |
| 2004 | 29% | +6% |
| 2003 | 23% | +3% |
| 2002 | 20% | +20% |
| 2001 | 0% | 0% |
| 2000 | 0% |